| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
19,990,000 |
| Market
Cap: |
3.10(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.155 - $0.155 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Synthetic Biologics is a clinical-stage company developing therapeutics designed to prevent and treat gastrointestinal (GI) diseases. Co.'s main clinical development candidates are: SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the GI tract to prevent microbiome damage, Clostridioides difficile infection, overgrowth of pathogenic organisms, the emergence of antimicrobial resistance and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase intended to treat both local GI and systemic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
240,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$159,974 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Riley Jeffrey Scott |
CEO and President |
• • – |
2013-01-02 |
4 |
B |
$1.78 |
$4,806 |
D/D |
2,700 |
2,700 |
2.73 |
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2012-10-29 |
4 |
B |
$1.60 |
$5,000,000 |
I/I |
3,125,000 |
3,125,000 |
1.5 |
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2012-10-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,675,768 |
|
- |
|
| Kuo James S |
Chairman, CEO & President |
• • – |
2011-08-30 |
4 |
B |
$0.69 |
$3,103 |
D/D |
4,500 |
4,500 |
2.73 |
- |
|
| Lyon Lyman Max Jr |
CEO & President |
• • – |
2009-12-09 |
4 |
D |
$0.45 |
$11,255 |
D/D |
(25,000) |
0 |
|
- |
|
| Lyon Lyman Max Jr |
CEO & President |
• • – |
2009-12-08 |
4 |
D |
$0.48 |
$9,526 |
D/D |
(20,000) |
25,000 |
|
- |
|
| Lyon Lyman Max Jr |
CEO & President |
• • – |
2009-12-07 |
4 |
A |
$0.38 |
$17,100 |
D/D |
45,000 |
45,000 |
|
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • – |
2008-04-11 |
4 |
B |
$0.79 |
$44,428 |
D/D |
50,000 |
375,246 |
2.81 |
- |
|
| Rudick A Joseph |
Director |
– • – |
2008-01-29 |
4 |
OE |
$0.09 |
$2,440 |
D/D |
27,106 |
57,267 |
|
- |
|
| Dorman Daniel J |
Director |
– • – |
2007-11-09 |
4 |
B |
$2.22 |
$563,283 |
I/I |
253,731 |
742,626 |
2.1 |
- |
|
| Holman Wayne George |
10% Owner |
– – • |
2007-11-09 |
4 |
OE |
$0.74 |
$457,953 |
D/D |
618,855 |
1,856,565 |
|
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-25 |
4 |
B |
$7.09 |
$103,281 |
D/D |
14,300 |
325,246 |
3.23 |
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-24 |
4 |
B |
$7.00 |
$57,025 |
D/D |
8,000 |
310,946 |
3.23 |
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-23 |
4 |
B |
$6.58 |
$200,351 |
D/D |
29,700 |
302,946 |
3.23 |
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-17 |
4 |
B |
$5.10 |
$131,171 |
D/D |
25,000 |
273,246 |
3.23 |
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-16 |
4 |
B |
$4.49 |
$391,962 |
D/D |
81,000 |
248,246 |
3.23 |
- |
|
| Kanzer Steve H |
CEO |
• • • |
2007-07-16 |
4/A |
B |
$4.49 |
$391,962 |
D/D |
81,000 |
248,246 |
3.23 |
- |
|
| Bisgaier Charles Phd |
President |
• • – |
2007-07-16 |
4 |
B |
$4.64 |
$46,400 |
D/D |
10,000 |
109,104 |
2.81 |
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • • |
2007-05-11 |
4 |
B |
$5.00 |
$140,350 |
D/D |
26,500 |
448,738 |
3.23 |
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • • |
2007-04-17 |
4 |
B |
$1.99 |
$133,640 |
D/D |
66,000 |
422,238 |
3.23 |
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • • |
2007-04-16 |
4 |
B |
$1.82 |
$311,940 |
D/D |
161,000 |
356,238 |
3.23 |
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • • |
2007-02-27 |
4 |
A |
$1.25 |
$125,000 |
D/D |
100,000 |
195,238 |
|
- |
|
| Kanzer Steve H |
Chief Executive Officer |
• • • |
2007-02-21 |
4 |
A |
$1.05 |
$100,000 |
D/D |
95,238 |
95,238 |
|
- |
|
| Dorman Daniel J |
Director |
– • – |
2007-02-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,522,382 |
|
- |
|
| Holman Wayne George |
10% Owner |
– – • |
2006-11-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,713,129 |
|
- |
|
63 Records found
|
|
Page 2 of 3 |
|
|
